Navigation Links
Conference to set the research agenda on Vitamin D in health and disease

An important conference on the actions of Vitamin D on human health is being hosted by Barts and The London Medical School and the MRC Asthma UK Centre in Allergic Mechanisms of Asthma.

Vitamin D has been known for some time to be important for healthy bones, now new research suggests it has possible benefits in other aspects of health including immune function, tuberculosis, asthma, diabetes, multiple sclerosis, gut function, skin, and the prostate, all of which will be addressed at the one-day event, being held on Tuesday 30 March at the Centre for Health Sciences in Whitechapel, London.

Attended by expert researchers from around the world the conference aims to stimulate debate, advance understanding, and set the research agenda in this exciting and increasingly topical field.

The programme is as follows:

Session 1 Epidemiology and Diabetes

10.15am Dr Elina Hyppnen
University College London
Vitamin D in health and disease insights from epidemiology

10.45am Professor Chantal Mathieu
Laboratory for Experimental Medicine and Endocrinology, Katholieke Universiteit Leuven, Belgium
Vitamin D and type 1 diabetes mellitus

11.15am Dr Barbara Boucher
Barts and The London School of Medicine and Dentistry
Vitamin D and type 2 diabetes

Session 2 Immunomodulatory actions of Vitamin D

12.00pm Dr Jrgen Schauber
University of Munich, Germany
Vitamin D and the cutaneous innate immune system

12.30pm Professor Margherita Cantorna
Pennsylvania State University, USA
Vitamin D and autoimmune disease

1.00pm Professor Kasia Hawrylowicz
King's College London
Vitamin D, regulatory T cells and allergic disease

Session 3: Clinical aspects 1: prostate and gut

2.15pm Dr Luciano Adorini
Chief Scientific Officer
Intercept Pharma, Italy
Vitamin D receptor agonists in the treatment of inflammatory prostatic disease

2.45pm Dr Julian Walters
Imperial College, London
Vitamin D and the gut

Session 4 Clinical aspects 2: tuberculosis and multiple sclerosis

3.30pm Dr Adrian Martineau
Barts and The London School of Medicine and Dentistry
Vitamin D and tuberculosis

4.30pm Professor George Ebers
Oxford University
Vitamin D and multiple sclerosis

The event will be chaired by Professor Chris Griffiths of the Centre for Health Sciences at Barts and The London Medical School.


Contact: Alex Fernandes
Queen Mary, University of London

Related biology news :

1. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
2. Director of National Intelligence to Speak at Conference
3. Last chance for media to register for ECCO 14 -- the European Cancer Conference
4. Iowa State University conference examines developing bioeconomy
5. Minister Lunn to attend Union of BC Municipalities Pine Beetle Conference
6. Conference to examine role technology can play in helping US manage healthcare costs
7. Office of the Director of National Intelligence, CIO to Speak at Government Security Conference
8. Director of National Intelligence to Speak at Conference
9. Cardiologists and heart surgeons meet for Controversies and Advances conference
10. Conference on sustainable transportation is Oct. 29-31
11. UD hosts conference on knowledge-based partnerships Nov. 2
Post Your Comments:
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/9/2015)... , Nov. 9, 2015  Synaptics Inc. (NASDAQ: ... today announced broader entry into the automotive market with ... match the pace of consumer electronics human interface innovation. ... are ideal for the automotive industry and will be ... Europe , Japan ...
(Date:10/29/2015)... MINNETONKA, Minn. , Oct. 29, 2015   ... that supports the entire spectrum of clinical research, is ... the Minnesota High Tech Association (MHTA) as one of ... in the "Software – Small and Growing" category. The ... and individuals who have shown superior technology innovation and ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... 24, 2015  Asia-Pacific (APAC) holds the third-largest ... market. The trend of outsourcing to low-cost locations ... higher volume share for the region in the ... margins in the CRO industry will improve. ... ( ), finds that the market earned ...
(Date:11/24/2015)... ... 2015 , ... Copper is an essential micronutrient that all ... copper is also toxic to cells. With a $1.3 million award from the ... a systematic study of copper in the bacteria Pseudomonas aeruginosa (P. aeruginosa), a ...
Breaking Biology Technology: